Clinical Trial Update: Lucentis for Treatment of Macular Edema

View source ↗

Summary

A completed clinical trial evaluating Lucentis (ranibizumab) for cystoid macular edema has been reported. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Retina Institute of Hawaii | Conditions: Cystoid Macular Edema | Status: COMPLETED